Bayer and Janssen's novel oral anticoagulant (NOAC) Xarelto can be used in place of warfarin in atrial fibrillation patients undergoing cardioversion to restore normal heart rhythm, according to a new ...

Bayer chief executive Bill Anderson has said that newer product launches have offset the decline in sales of anticoagulant Xarelto in the first quarter, and he is confident that this will continue ...

Hi. I'm Tim and this is my pronunciation workshop. Here, I'm going to show you how English is really spoken. Come on, let's go inside. You see this? This is my lunch - well, either that, or it's some ...

This is the fifth of eight voiceless consonant programmes in our series of videos that explore the sounds of English. This is the fifth of seven short vowel programmes in our series of videos that ...

Andexanet alfa (Andexxa) will officially be taken off the U.S. market this month as an emergency reversal medication for contemporary blood thinners. "The Biologics License Application for Andexxa has ...